BH3-Interacting Domain Death Agonist (BID) Peptide

Este producto es parte de BID - BH3-interacting domain death agonist
Product Graph
195€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
BH3-Interacting Domain Death Agonist (BID) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269659
tested applications
P-ELISA

Description

BH3-Interacting Domain Death Agonist (BID) Peptide is a synthetic peptide. This peptide is used in the production of

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
BH3-Interacting Domain Death Agonist (BID)
Host
Synthetic
Assay Type
Activity: Not tested.
Sequence Fragment: C-Terminus: C-TYVRSLARNGMD
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Size 1
100 µg
Form
Lyophilized
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
637
NCBI Accession
NP_932070.1, NP_001187.1, NP_932071.1
Alias
p22 BID,FP497
Background
Protein BID
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in deionized water.

Descripción

Related Products

EH0983

Human BID (BH3-interacting domain death agonist) ELISA Kit

Ver Producto
EH4219

Human Cleaved BID/TBID (Cleaved BH3-interacting domain death agonist) ELISA Kit

Ver Producto
FNab00892

BID antibody

The major proteolytic product p15 BID allows the release of cytochrome c(By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2.

Ver Producto